Kyverna Therapeutics, Inc. (KYTX)
8.37
-0.27
(-3.12%)
USD |
NASDAQ |
Aug 28, 16:00
8.37
0.00 (0.00%)
After-Hours: 20:00
Kyverna Therapeutics EPS Diluted (TTM) : -2.936 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.936 |
| March 31, 2026 | -3.280 |
| December 31, 2025 | -3.655 |
| September 30, 2025 | -3.721 |
| June 30, 2025 | -3.673 |
| March 31, 2025 | -3.367 |
| December 31, 2024 | -3.458 |
| September 30, 2024 | -3.070 |
| Date | Value |
|---|---|
| June 30, 2024 | -2.629 |
| March 31, 2024 | -2.265 |
| December 31, 2023 | -1.40 |
| September 30, 2023 | -1.118 |
| June 30, 2023 | -0.759 |
| March 31, 2023 | -0.4554 |
| December 31, 2022 | -0.197 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Cartesian Therapeutics, Inc. | -5.939 |
| Allogene Therapeutics, Inc. | -0.6651 |
| Beam Therapeutics, Inc. | -0.86 |
| Arrowhead Pharmaceuticals, Inc. | -2.243 |
| Oncolytics Biotech, Inc. | -0.2725 |